TOP TEN ARTICLES / RECOMMENDED READING:

Oncology

1. Wilms' tumor.**
2. Osteosarcoma.
3. Rhabdomyosarcoma: an overview.
4. Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment. (choose via ScienceDirect)

5. Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.
6. Biology and treatment of neuroblastoma.**
7. The Children's Hospital Oakland: Hematology/Oncology Handbook (Paperback)
   by Caroline Hastings, MD*
8. Childhood and adolescent lymphoid and myeloid leukemia.
9. Acute lymphoblastic leukemia.
10. Acute leukemia: a pediatric perspective. (choose via ScienceDirect)

11. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.

12. 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

    This article, prepared by the Infectious Diseases Society of America (IDSA) Fever and Neutropenia Guidelines Panel, updates guidelines established a decade ago by the Infectious Disease Society of America for the use of antimicrobial agents to treat neutropenic patients with unexplained fever.

13. Cancer Pain Management in Children

Hematology

14. Management and therapy of sickle cell disease
    by Clarice D Reid; Samuel Charache; Bertram H Lubin*
15. Managing Anemia in Pediatric Office Practice: Part 1 (PIR)

The first in a series from Pediatrics in Review on how to manage anemia in the office setting, this article instructs readers to:

1. Compare and contrast the pathogenesis of iron deficiency anemia in toddlers and older children.
2. Describe the genetic defects resulting in beta-thalassemia and hemoglobin E and differentiate between heterozygous and homozygous defects.
3. Outline the molecular basis for alpha-thalassemia syndromes, including silent carrier, alpha-thalassemia trait, hemoglobin H, and Bart’s hemoglobinopathy.
4. Describe the pathogenesis of spherocytes in herediatry spherocytosis and the reasons for the shortened red cell survival.
5. Characterize the risk of "aplastic crisis" in hereditary spherocytosis and the requisite monitoring and management.

16. Managing Anemia in Pediatric Office Practice: Part 2 (PIR)

After completing the second article from this series, readers should be able to:

1. Recognize the signs and symptoms of sickle cell vaso-occlusive crisis.
2. Explain the factors contributing to the pathogenesis of sickle cell vaso-occlusion.
3. Delineate the reasons for the heightened susceptibility to infection in sickle cell disease.
4. Describe the biochemical basis for hemolysis in glucose-6-phosphate dehydrogenase deficiency.
5. Compare and contrast Diamond-Blackfan anemia and transient erythroblastopenia of childhood.

* Denotes hard copies available in residency office or section offices.

** For references available through MDConsult, visit this page first and click on open generic version. Then, in a separate browser window, click on one of the links below. You can also obtain a personal login through the John Crerar library.